FindTrial
Sign In

The look for investigations that can help in finding the end of treatment in spinal tuberculosis

Evaluation of investigations suitable for the endpoint of treatment in spinal tuberculosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/03/023835
Enrollment
50
Registered
2020-03-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M858- Other specified disorders of bonedensity and structure

Interventions

Intervention1: Nil: No Intervention to be done.Only follow up observational study to be done for Spinal Tuberculosis patients receiving anti tuberculous drugs as per Revised National Tuberculosis cont

Sponsors

Dr Tensubam Tomthin Meetei
Lead Sponsor
Dr Sarvdeep Singh Dhatt
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1) Age more than 18 years and less than 70 years 2) Confirmed cases of Spinal Tuberculosis 3) Patients who have received anti tubercular treatment for at least 6 months

Exclusion criteria

Exclusion criteria: 1) Age less than 18 years and more than 70 years 2) Associated comorbidities like Diabetes mellitus, Hypertension. 3) Patients who underwent or undergoing surgery

Design outcomes

Primary

MeasureTime frame
Cured status of spinal tuberculosis following anti tuberculous treatmentTimepoint: 18 months—

Secondary

MeasureTime frame
Best investigation for finding the cured statusTimepoint: 18 months—

Countries

India

Contacts

Public ContactDr Tensubam Tomthin Meetei

PGIMER,CHANDIGARH

sdhatt@yahoo.com9402294517

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026